default author photo

Paul M. Sondel

University of Wisconsin-Madison

716 Langdon Street

Madison, WI 53706-1481

United States

SCHOLARLY PAPERS

1

DOWNLOADS

51

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Improved Clinical Responses with the Concomitant Use of an Anti-GD2 Monoclonal Antibody During Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma: A New Treatment Paradigm

Number of pages: 31 Posted: 08 Sep 2018
St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, Provenance Biopharmaceuticals, Duke-NUS Graduate Medical School Singapore, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital, University of Wisconsin-Madison, St. Jude Children’s Research Hospital - Department of Oncology, St. Jude Children’s Research Hospital - Department of Oncology and University of Wisconsin-Madison
Downloads 51

Abstract:

Loading...

high-risk neuroblastoma, anti-gd2, hu14.18K322A, response